OPEN LAB REPORTS CLEAR PRODUCT DATA SECURE ORDERING
Bag
Premium capped GLP pens beside a luminous DNA helix in a cobalt laboratory

Weight Management

RETATRUTIDE 40mg

A 40mg triple GLP-1, GIP and glucagon receptor agonist product presented for metabolic research.

Check the current price and availability, read the product information, then use the configured dosage calculator or add the product to your bag.

£169.99

Available to order

Product-specific reports

Reports matched to this strength.

PurityRETATRUTIDE 40mg · 99.029% puritySterilityRETATRUTIDE 40mg · Sterility report

After you place an order, secure payment instructions are sent separately by email. No payment is collected on this page.

Product details

Retaklik (retatrutide) is a triple agonist targeting the GLP-1, GIP, and glucagon receptors, designed to support effortless weight control and improve glucose balance. By activating these key metabolic pathways, it recalibrates appetite, enhances energy output, and boosts overall metabolic efficiency for a smoother, more empowered transformation experience.

Research context

A 40mg triple GLP-1, GIP and glucagon receptor agonist product presented for metabolic research.

Ingredients

See the supplied product label and accompanying documentation for full composition details.

Supplied directions

Follow the supplied product directions and configured dosage information. Seek appropriate professional advice where needed.

Product information is provided for reference only. It is not a diagnosis, treatment recommendation or substitute for advice from an appropriately qualified professional.

No approved reviews yet for RETATRUTIDE 40mg.Be the first to review

Please confirm your age

PEPHOUSE content and products are intended for adults. Your choice is remembered on this device.

Your privacy, your choice

We use essential storage for your bag and preferences. Optional analytics remain off unless you accept them.